Cite
APA Citation
Svenningsson, P., Odin, P., Dizdar, N., Johansson, A., Grigoriou, S., Tsitsi, P., Wictorin, K., Bergquist, F., Nyholm, D., Rinne, J., Hansson, F., Sonesson, C., Tedroff, J., & , (2020). a Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia. Movement disorders, 35(6), 1046–1054. http://access.bl.uk/ark:/81055/vdc_100103760989.0x000016